HYDRINITY Expands Regenerative Skincare Portfolio with Two New High-Performance Treatments
Event summary
- HYDRINITY launched RetaXome™ Retinal Boost Treatment Pads ($90) and CÉLTHERA™ Overnight Repair Cream ($160) on September 14, 2026.
- The products combine biomimetic exosome delivery and multi-acid resurfacing with overnight repair technologies.
- HYDRINITY's network includes over 6,000 dermatologist and aesthetic professional practices across 45 countries.
- The launch coincides with the 'Tomorrow's Skin Starts Tonight' marketing campaign.
The big picture
HYDRINITY's expansion into regenerative skincare with advanced delivery systems aligns with the broader industry trend towards personalized, high-performance treatments. The company's focus on overnight repair and resurfacing technologies positions it to capture a growing segment of the professional skincare market, particularly as consumers seek accelerated results without compromising skin health.
What we're watching
- Market Penetration
- Whether HYDRINITY can sustain its rapid growth across 45 countries through its extensive professional network.
- Product Differentiation
- How the combination of retinal technology and exosome-delivered vegan Epidermal Growth Factor will position HYDRINITY against competitors.
- Consumer Adoption
- The pace at which consumers adopt the new nighttime regimen, given the premium pricing of the products.
Related topics